Open Letter to Shareholders from Pluristem Therapeutics CEO Zami Aberman
Dear Shareholders, As we close in on the end of the calendar year, it is important to look back upon all that we at Pluristem have accomplished… Read more »
3 Contenders To Be The First Profitable Stem Cell Company
By Ryan Pollack, SeekingAlpha.com Every day is a day closer to a disease being treated, or even cured, by a stem cell therapy. The medical field is… Read more »
The Promising Cells Presented by International Stem Cell Corporation
Ken Aldrich of International Stem Cell Corporation (ISCO.OB) speaks on the latest research involving stem cell technology utilizing unfertilized eggs, as a basis for cell generation with… Read more »
FDA Approves Fibrocell’s Stem Cell Wrinkle Smoother
Fibrocell Science Inc. (FCSC) won U.S. approval for an injectible wrinkle treatment that uses a patient’s own stem cells to restore elasticity to the skin. The Food… Read more »
Stem cells from body fat promising
A San Diego-based company is breaking new ground in the field of regenerative medicine with a system that uses patients’ own body fat to generate stem cells… Read more »
Neuralstem Announces First Patient Treated in ALS Stem Cell Trial
ROCKVILLE, Md., Jan. 21 /PRNewswire-FirstCall/ — Neuralstem, Inc. (NYSE Amex: CUR) announced that the first ALS patient was treated with its spinal cord stem cells yesterday at… Read more »
International Stem Cell Corporation and Absorption Systems Announce Potential Stem Cell Alternative to Live Animal Testing for Corneal Damage
OCEANSIDE, Calif. & EXTON, Pa.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB:ISCO)), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces… Read more »